🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆
Updated 11 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Michigan

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

26
Recruiting now
31
Studies tracked
Michigan
Selected state
Active Phase 1/Phase 2
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia
Ossium Health, Inc. · started 2024-08-16
California · Florida · Georgia · Michigan · Oregon · Tennessee · Texas · Utah
NCT05589896 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
Advanced Solid Tumors
FoRx Therapeutics AG · started 2025-07-22
California · Michigan · Missouri · Oregon · Texas · Virginia
NCT07356453 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Neoplasms
Janssen Research & Development, LLC · started 2023-12-20
California · Colorado · Florida · Georgia · Michigan · New Jersey · New York · North Carolina
NCT06150157 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC · started 2026-03-23
Arizona · California · Florida · Indiana · Kansas · Massachusetts · Michigan · Missouri
NCT07299019 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Bayer · started 2024-08-28
California · Florida · Georgia · Illinois · Maryland · Massachusetts · Michigan · Minnesota
NCT06452277 on ClinicalTrials.gov ↗
Recruiting Phase 3
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
Quetzal Therapeutics · started 2026-06-08
Alabama · California · Georgia · Kentucky · Maryland · Michigan · New York · Ohio
NCT07504458 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Bayer · started 2025-03-21
Alabama · California · Colorado · Florida · Massachusetts · Michigan · New York · Tennessee
NCT06914128 on ClinicalTrials.gov ↗
Recruiting Phase 1
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Endometrial Cancer, Cervical Cancer, Ovarian Cancer, Urothelial Carcinoma
SystImmune Inc. · started 2024-02-09
Alabama · California · Florida · Georgia · Illinois · Massachusetts · Michigan · Missouri
NCT06293898 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Obesity, Overweight
Boehringer Ingelheim · started 2026-06-30
Alabama · California · Florida · Georgia · Kentucky · Michigan · Missouri · North Carolina
NCT07662122 on ClinicalTrials.gov ↗
Recruiting Phase 1
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
Triple Negative Breast Cancer (TNBC)
Immunomic Therapeutics, Inc. · started 2026-07-14
Michigan · Tennessee
NCT07652242 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Locally Advanced / Metastatic Solid Tumors
Crescent Biopharma, Inc. · started 2026-02-17
Alabama · California · Colorado · District of Columbia · Florida · Michigan · New York · Ohio
NCT07335497 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Alopecia Areata
Pfizer · started 2026-07-30
California · Florida · Illinois · Indiana · Iowa · Maryland · Michigan · North Carolina
NCT07733765 on ClinicalTrials.gov ↗
Recruiting
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Coronary Artery Disease, High Risk Percutaneous Coronary Intervention, Interventional Cardiology, Mechanical Circulatory Support
Supira Medical · started 2026-05-11
California · Georgia · Illinois · Michigan · Minnesota · Missouri · New York · Ohio
NCT07296744 on ClinicalTrials.gov ↗
Active Phase 3
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
Hormone-Sensitive Prostate Cancer
AstraZeneca · started 2020-07-13
Arizona · California · Colorado · Connecticut · Florida · Illinois · Maryland · Michigan
NCT04493853 on ClinicalTrials.gov ↗
Recruiting
Shoulder Innovations Clinical Data Registry
Shoulder Arthroplasty
Shoulder Innovations · started 2024-10-23
Alabama · California · Colorado · Florida · Georgia · Maryland · Massachusetts · Michigan
NCT06754150 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Genentech, Inc. · started 2020-11-06
California · Colorado · Connecticut · District of Columbia · Florida · Illinois · Massachusetts · Michigan
NCT04302025 on ClinicalTrials.gov ↗
Recruiting
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Heart Failure
EBR Systems, Inc. · started 2025-11-03
Arizona · Arkansas · Florida · Michigan · Missouri · New York · Ohio · Pennsylvania
NCT07098858 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Chondral Defect, Osteochondritis Dissecans (OCD), Articular Cartilage Defect, Articular Cartilage Disorder of Knee
Vericel Corporation · started 2018-10-24
California · Louisiana · Maryland · Michigan · New York · Ohio · Pennsylvania · Texas
NCT03588975 on ClinicalTrials.gov ↗
Recruiting Phase 4
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
Muscular Atrophy, Spinal
Hoffmann-La Roche · started 2024-08-14
Arkansas · California · Colorado · Florida · Georgia · Michigan · Pennsylvania · Texas
NCT05861999 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Knee Cartilage Defects
Medipost, Inc. · started 2026-03-11
Alabama · Arizona · California · Colorado · Kentucky · Louisiana · Michigan · Minnesota
NCT07339111 on ClinicalTrials.gov ↗
Recruiting Phase 3
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc. · started 2025-08-28
Arizona · Arkansas · California · Colorado · Florida · Maryland · Michigan · Missouri
NCT06960213 on ClinicalTrials.gov ↗
Recruiting Phase 2
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Low Grade Upper Tract Urothelial Carcinoma
Tyra Biosciences, Inc · started 2025-12-22
Florida · Georgia · Illinois · Indiana · Massachusetts · Michigan · Missouri · New Jersey
NCT07265947 on ClinicalTrials.gov ↗
Active Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Seagen, a wholly owned subsidiary of Pfizer · started 2020-08-07
Alabama · California · Colorado · Kansas · Kentucky · Massachusetts · Michigan · Missouri
NCT04227847 on ClinicalTrials.gov ↗
Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
Peripheral Vascular Disease, Peripheral Arterial Disease
Cook Research Incorporated · started 2026-04-17
Connecticut · Florida · Iowa · Michigan · Mississippi · South Carolina · Texas
NCT07144150 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Diabetes Mellitus, Type 2
Novo Nordisk A/S · started 2026-08-04
Connecticut · Florida · Georgia · Illinois · Indiana · Iowa · Michigan · New York
NCT07282613 on ClinicalTrials.gov ↗
Active Phase 3
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca · started 2020-10-02
Arizona · Illinois · Kansas · Massachusetts · Michigan · Minnesota · Missouri · Nevada
NCT04590963 on ClinicalTrials.gov ↗
Recruiting Phase 3
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Sjögren´s Disease
Novartis Pharmaceuticals · started 2026-07-16
Arizona · Florida · Illinois · Michigan · North Carolina · Oklahoma · Tennessee · Texas
NCT07621809 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Episodic Migraine
H. Lundbeck A/S · started 2023-06-08
Connecticut · Florida · Georgia · Kentucky · Maryland · Michigan · New York · North Carolina
NCT05897320 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Multiple Myeloma, Secondary Immunodeficiency
Takeda · started 2026-01-14
Alabama · California · Kansas · Maryland · Michigan · Missouri · New York
NCT06980480 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC · started 2025-12-18
California · Colorado · District of Columbia · Florida · Georgia · Illinois · Michigan · Missouri
NCT07266831 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc. · started 2025-05-06
California · Michigan · Nebraska · New York · Ohio · Wisconsin
NCT06680037 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 103 Florida · 87 Illinois · 56 Arizona · 44 New York · 43 Georgia · 42 Texas · 39 Colorado · 31 Michigan · 31 Alabama · 29 Massachusetts · 28 Maryland · 27 Missouri · 25 Connecticut · 24 Ohio · 23 Kentucky · 23

Browse by condition

Obesity · 5 Overweight · 4 Glioblastoma · 3 Heart Failure · 3 Ovarian Cancer · 3 Systemic Sclerosis · 2 Recurrent Pericarditis · 2 Pancreatic Cancer · 2 Acute Myeloid Leukemia · 2 Advanced Solid Tumors · 2 Endometrial Neoplasms · 2 Soft Tissue Sarcoma (STS) · 2 Breast Neoplasms · 2 Pulmonary Hypertension · 2 Non-Small Cell Lung Cancer · 2 Breast Cancer · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/michigan (Accessed: 11 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.